The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended an extension of indication for dapivirine vaginal ring 25 mg to include its use in women ...
The 39 million U.S. women who use contraception got a new option in October 2001 when the Food and Drug Administration (FDA) approved the first vaginal contraceptive ring (NuvaRing). The vaginal ring ...
PITTSBURGH – March 21, 2024 – Researchers who are developing a dual-purpose vaginal ring to protect women against both HIV and unplanned pregnancy for a month at a time have begun a study to evaluate ...
The vaginal contraceptive ring represents one of the more recent innovations in hormonal birth control, offering a unique delivery system that combines convenience with effectiveness. Unlike daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results